ENDURE BIO Trademark

Trademark Overview

On Wednesday, December 1, 2021, a trademark application was filed for ENDURE BIO with the United States Patent and Trademark Office. The USPTO has given the ENDURE BIO trademark a serial number of 97151134. The federal status of this trademark filing is REGISTERED as of Tuesday, August 1, 2023. This trademark is owned by Endure Biotherapeutics, Inc.. The ENDURE BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of pharmaceuticals and drug delivery systems; research and design services relating to pharmaceuticals and drug delivery systems; research in the field of pharmaceutical preparations; providing medical and scientific research information in the field of clinical trials
endure bio

General Information

Serial Number97151134
Word MarkENDURE BIO
Filing DateWednesday, December 1, 2021
Status700 - REGISTERED
Status DateTuesday, August 1, 2023
Registration Number7128384
Registration DateTuesday, August 1, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Disclaimer with Predetermined Text"BIO"
Goods and ServicesResearch and development in the field of pharmaceuticals and drug delivery systems; research and design services relating to pharmaceuticals and drug delivery systems; research in the field of pharmaceutical preparations; providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code042
First Use Anywhere DateTuesday, May 31, 2022
First Use In Commerce DateTuesday, May 31, 2022

Trademark Owner History

Party NameEndure Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEncinitas, CA 92024
Party NameEndure Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEncinitas, CA 92024
Party NameEndure Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEncinitas, CA 92024

Trademark Events

Event DateEvent Description
Tuesday, August 1, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 1, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 27, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, June 24, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 24, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 8, 2023USE AMENDMENT FILED
Friday, March 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 8, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 19, 2022NON-FINAL ACTION E-MAILED
Saturday, November 19, 2022NON-FINAL ACTION WRITTEN
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 4, 2021NEW APPLICATION ENTERED

Related Keywords

endure research field systems drug delivery pharmaceuticals scientific medical information trials